Arch Therapeutics (ARTH) Short Interest Ratio & Short Volume $0.26 +0.02 (+9.33%) As of 02/21/2025 03:54 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Arch Therapeutics Short Interest DataArch Therapeutics (ARTH) has a short interest of 12,100 shares. This marks a 0.83% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.1, indicating that it would take 1.1 days of the average trading volume of 1,598 shares to cover all short positions.Current Short Interest12,100 sharesPrevious Short Interest12,000 sharesChange Vs. Previous Month+0.83%Dollar Volume Sold Short$2,190.10Short Interest Ratio1.1 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares4,740,000 sharesPercentage of Shares Shorted0.26%Today's Trading Volume1,241 sharesAverage Trading Volume1,598 sharesToday's Volume Vs. Average78% Short Selling Arch Therapeutics? Sign up to receive the latest short interest report for Arch Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartARTH Short Interest Over TimeARTH Days to Cover Over TimeARTH Percentage of Float Shorted Over Time Arch Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/202512,100 shares $2,190.10 +0.8%N/A1.1 $0.18 1/15/202512,000 shares $2,042.40 -3.2%N/A3.9 $0.17 12/31/202412,400 shares $2,108.00 -0.8%N/A0.8 $0.17 12/15/202412,500 shares $3,074.69 +0.8%N/A0.4 $0.25 11/30/202412,400 shares $2,647.40 -6.1%N/A1.4 $0.21 11/15/202413,200 shares $3,418.80 -9.6%N/A0.9 $0.26 10/31/202414,600 shares $4,567.98 +16.8%N/A0.8 $0.31 10/15/202412,500 shares $3,375.00 -28.2%N/A0.4 $0.27 9/30/202417,400 shares $10,614.00 +40.3%N/A0.6 $0.61 9/15/202412,400 shares $9,300.00 No ChangeN/A4 $0.75 Get the Latest News and Ratings for ARTH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arch Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/202412,400 shares $6,973.76 No ChangeN/A2.5 $0.56 8/15/202412,400 shares $8,184.00 -3.9%N/A3.4 $0.66 7/31/202412,900 shares $9,418.29 +2.4%N/A5.4 $0.73 7/15/202412,600 shares $7,867.44 -0.8%N/A2.3 $0.62 6/30/202412,700 shares $10,871.20 -5.2%N/A2.9 $0.86 6/15/202413,400 shares $14,673.00 No ChangeN/A2.5 $1.10 5/31/202413,400 shares $15,142.00 No ChangeN/A3.9 $1.13 5/15/202413,400 shares $13,936.00 +8.1%N/A2.7 $1.04 4/30/202412,400 shares $14,632.00 -5.3%N/A2.9 $1.18 4/15/202413,100 shares $14,803.00 +5.7%N/A2 $1.13 3/31/202412,400 shares $24,304.00 No ChangeN/A3.2 $1.96 3/15/202412,400 shares $26,040.00 No ChangeN/A2.1 $2.10 2/29/202412,400 shares $33,480.00 -1.6%N/A1 $2.70 2/15/202412,600 shares $37,800.00 -41.4%N/A1.5 $3.00 1/15/202431,300 shares $167,455.00 No ChangeN/A1.4 $5.35 12/31/202331,300 shares $226,612.00 +3.6%N/A0.5 $7.24 12/15/202330,200 shares $138,920.00 +1.3%N/A0.3 $4.60 11/30/202329,800 shares $178,800.00 +52.8%N/A0.3 $6.00 11/15/202319,500 shares $39,000.00 +828.6%N/A0.7 $2.00 10/31/20232,100 shares $1,995.00 No ChangeN/A0.8 $0.95 10/15/20232,100 shares $1,260.00 No ChangeN/A0.3 $0.60 9/30/20232,100 shares $2,730.00 -43.2%N/A0.6 $1.30 9/15/20233,700 shares $9,620.00 +76.2%N/A0.3 $2.60 8/31/20232,100 shares $3,087.00 -4.6%N/A1.3 $1.47 8/15/20232,200 shares $3,498.00 -12.0%N/A0.5 $1.59 7/31/20232,500 shares $5,175.00 +13.6%N/A1.8 $2.07 7/15/20232,200 shares $6,270.00 +144.4%N/A5.5 $2.85 6/30/2023900 shares $2,700.00 +800.0%N/A0.8 $3.00 6/15/2023100 shares $325.00 No ChangeN/A0.1 $3.25 5/15/2023200 shares $550.00 +100.0%N/A0.2 $2.75Has Trump finally met his match? (Ad)Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again?Click here for his emergency broadcast... 4/30/2023100 shares $275.00 -80.0%N/A0.1 $2.75 4/15/2023500 shares $1,650.00 +66.7%N/A0.2 $3.30 3/31/2023300 shares $1,050.00 -40.0%N/A0.1 $3.50 3/15/2023500 shares $1,950.00 No ChangeN/A0.4 $3.90 2/28/2023500 shares $1,750.00 No ChangeN/A0.3 $3.50 1/15/20239,300 shares $322.71 No ChangeN/A0.1 $0.03 11/30/202219,700 shares $886.50 +579.3%N/A0.1 $0.05 11/15/20222,900 shares $145.00 +16.0%N/A0 $0.05 10/31/20222,500 shares $116.00 -99.0%N/A0 $0.05 10/15/2022243,200 shares $9,728.00 +2,332.0%N/A0.2 $0.04 9/30/202210,000 shares $192.00 +108.3%N/A0 $0.02 9/15/20224,800 shares $76.80 No ChangeN/A0 $0.02 8/15/2022500 shares $20.50 No ChangeN/A0 $0.04 7/15/20224,100 shares $180.40 No ChangeN/A0 $0.04 6/15/202235,100 shares $1,755.00 No ChangeN/A0.1 $0.05 5/15/20224,000 shares $320.00 No ChangeN/A0 $0.08 4/15/202216,100 shares $1,432.90 +1,912.5%N/A0.1 $0.09 3/31/2022800 shares $78.08 -46.7%N/A0 $0.10 3/15/20221,500 shares $141.00 +275.0%N/A0 $0.09 2/28/2022400 shares $39.96 -98.7%N/A0 $0.10 2/15/202230,800 shares $2,987.60 No ChangeN/A0.1 $0.10 1/15/202281,000 shares $8,399.70 +16.2%N/A0.3 $0.10 12/31/202169,700 shares $6,621.50 -74.0%N/A0.1 $0.10 12/15/2021268,000 shares $31,892.00 +53,500.0%N/A0.3 $0.12 11/30/2021500 shares $49.30 +150.0%N/A0 $0.10 11/15/2021200 shares $22.00 -99.6%N/A0 $0.11 10/29/202151,100 shares $6,055.35 +132.3%N/A0.1 $0.12 10/15/202122,000 shares $2,376.00 -63.0%N/A0 $0.11 9/30/202159,500 shares $7,735.00 -43.7%N/A0.2 $0.13 9/15/2021105,600 shares $10,296.00 +345.6%N/A0.1 $0.10 8/31/202123,700 shares $1,623.45 -86.4%N/A0 $0.07 8/13/2021173,800 shares $16,041.74 -6.9%N/A0.2 $0.09 7/30/2021186,600 shares $16,794.00 -3.1%N/A0.4 $0.09 7/15/2021192,600 shares $17,334.00 +11.9%N/A0.3 $0.09 6/30/2021172,100 shares $16,315.08 -9.1%N/A0.2 $0.09 6/15/2021189,400 shares $18,475.97 -18.0%N/A0.2 $0.10 5/28/2021230,900 shares $23,090.00 -15.9%N/A0.4 $0.10 5/14/2021274,700 shares $33,650.75 -25.6%N/A1.1 $0.12 4/30/2021369,000 shares $47,896.20 -5.5%N/A0.5 $0.13 4/15/2021390,500 shares $44,907.50 -56.0%N/A0.4 $0.12 3/31/2021887,000 shares $132,606.50 +72.7%N/A3.2 $0.15 3/15/2021513,500 shares $89,297.65 +79.7%N/A1 $0.17 2/26/2021285,700 shares $47,997.60 -13.7%N/A0.3 $0.17 2/12/2021331,100 shares $56,287.00 -8.9%N/A0.8 $0.17 1/29/2021363,600 shares $61,812.00 +12.9%N/A1.1 $0.17 1/15/2021379,500 shares $63,376.50 +10.5%N/A0.6 $0.17 12/31/2020313,300 shares $43,862.00 -17.4%N/A0.4 $0.14 12/15/2020379,500 shares $60,644.10 +10.5%N/A0.6 $0.16 11/30/2020343,300 shares $56,987.80 -1.6%N/A2.1 $0.17 11/15/2020348,800 shares $60,168.00 -5.0%N/A1.7 $0.17Elon Takes Aim at Social Security (Ad)Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social Security, finding what he says is widespread fraud across the agency.>>Here are the NINE stocks everyone will wish they own once Elon moves.<< 10/30/2020367,100 shares $61,305.70 -26.5%N/A0.8 $0.17 10/15/2020499,400 shares $87,395.00 -49.9%N/A2.2 $0.18 9/30/2020996,400 shares $172,576.48 +75.7%N/A1.5 $0.17 9/15/2020567,000 shares $98,601.30 -37.7%N/A0.8 $0.17 8/31/2020910,300 shares $151,838.04 -11.6%N/A1.3 $0.17 8/14/20201,029,800 shares $200,811.00 +6.3%N/A1 $0.20 7/31/2020968,800 shares $165,664.80 -3.7%N/A2.8 $0.17 7/15/20201,006,400 shares $161,024.00 -13.0%N/A2.2 $0.16 6/30/20201,156,400 shares $196,588.00 -13.7%N/A1.7 $0.17 6/15/20201,339,900 shares $264,630.25 -1.3%N/A1.4 $0.20 5/29/20201,357,600 shares $298,672.00 +5.6%N/A3 $0.22 5/15/20201,286,000 shares $237,910.00 +3.0%N/A3.6 $0.19 4/30/20201,249,100 shares $254,191.85 +22.5%N/A3.5 $0.20 4/15/20201,019,700 shares $209,548.35 -0.2%N/A2.7 $0.21 3/31/20201,022,100 shares $204,420.00 -3.5%N/A1.3 $0.20 3/13/20201,058,700 shares $201,153.00 +0.4%N/A2.5 $0.19 2/28/20201,055,000 shares $232,100.00 -1.6%N/A4.9 $0.22 ARTH Short Interest - Frequently Asked Questions What is Arch Therapeutics' current short interest? Short interest is the volume of Arch Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 12,100 shares of ARTH short. Learn More on Arch Therapeutics' current short interest. What is a good short interest ratio for Arch Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ARTH shares currently have a short interest ratio of 1.0. Learn More on Arch Therapeutics's short interest ratio. Is Arch Therapeutics' short interest increasing or decreasing? Arch Therapeutics saw a increase in short interest in the month of January. As of January 31st, there was short interest totaling 12,100 shares, an increase of 0.8% from the previous total of 12,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Arch Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "medical equipment" compare to Arch Therapeutics: Heart Test Laboratories, Inc. (4.05%), Sintx Technologies, Inc. (2.58%), Autonomix Medical, Inc. (11.44%), Catheter Precision, Inc. (1.09%), QHSLab, Inc. (0.01%), Bone Biologics Co. (29.06%), ENDRA Life Sciences Inc. (6.18%), Venus Concept Inc. (1.77%), Vycor Medical, Inc. (0.00%), Sharps Technology, Inc. (33.45%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Arch Therapeutics stock? Short selling ARTH is an investing strategy that aims to generate trading profit from Arch Therapeutics as its price is falling. ARTH shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Arch Therapeutics? A short squeeze for Arch Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ARTH, which in turn drives the price of the stock up even further. How often is Arch Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARTH, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies HSCS Short Interest SINT Short Interest AMIX Short Interest VTAK Short Interest USAQ Short Interest BBLG Short Interest NDRA Short Interest VERO Short Interest VYCO Short Interest STSS Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ARTH) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredThis quote from Elon says it all… (AI Breakthrough)MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arch Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arch Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
